![Adrian Senderowicz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Senderowicz
Director/Board Member at
PUMA BIOTECHNOLOGY, INC.
Net worth: 245 970 $ as of 31/08/2026
Profile
Adrian M.
Senderowicz is currently an Independent Director at Puma Biotechnology, Inc. since 2015, a Director at Step Pharma SAS since 2021, and an Independent Director at Anavex Life Sciences Corp.
Formerly, Dr. Senderowicz was Senior Medical Director-Oncology Division at AstraZeneca PLC from 2008 to 2012, Chief Medical Officer & Senior Vice President at Cerulean Pharma, Inc. from 2015 to 2017, Chief Medical Officer & VP-Medical Development at Tokai Pharmaceuticals, Inc. from 2012 to 2013, Chief Medical Officer & Senior Vice President at Constellation Pharmaceuticals, Inc. from 2017 to 2020, Chief Medical Officer & SVP-Regulatory Affairs at Ignyta, Inc. from 2014 to 2015, Chief Medical Officer & Senior Vice President at Daré Bioscience, Inc. from 2015 to 2017, and Vice President-Global Regulatory Oncology at Sanofi from 2013 to 2014.
Other former roles include Non-Executive Director at Oncoinvent ASA (Old), Head-Prostate Cancer Clinic at National Institutes of Health, and Clinical Team Leader-Oncology Division at US Food & Drug Administration.
Education includes a doctorate from Universidad de Buenos Aires.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/06/2026 | 27,000 ( 0.05% ) | 245 970 $ | 31/08/2026 |
Adrian Senderowicz active positions
| Companies | Position | Start |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Director/Board Member | 11/08/2015 |
| ANAVEX LIFE SCIENCES CORP. | Director/Board Member | - |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Director/Board Member | 06/10/2021 |
Former positions of Adrian Senderowicz
| Companies | Position | End |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 22/06/2020 |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Chief Tech/Sci/R&D Officer | 15/06/2017 |
| DARÉ BIOSCIENCE, INC. | Chief Tech/Sci/R&D Officer | 01/06/2017 |
| IGNYTA INC | Chief Tech/Sci/R&D Officer | 01/04/2015 |
| SANOFI | Corporate Officer/Principal | 01/08/2014 |
Training of Adrian Senderowicz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Anavex Life Sciences Corp.
 Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Health Technology |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Health Technology |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
Daré Bioscience, Inc.
 Daré Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Adrian Senderowicz
